NEPHCURE KIDNEY INTERNATIONAL
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$3,897,873
Cash & Equivalents
92%
Other Assets
3%
Receivables (Non-Related)
3%
Prepaid Expenses
2%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$880,264
Payables & Accruals
90%
Other Liabilities
10%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$3,372,669
$3,597,061
+7%
Receivables (Non-Related)
$67,431
$97,489
+45%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$90,552
$69,896
-23%
Investments
-
-
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
$333,567
$133,427
-60%
Total Assets
$3,864,219
$3,897,873
+1%
Liabilities
2023
2024
Change
Payables & Accruals
$480,274
$789,144
+64%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$218,168
$91,120
-58%
Total Liabilities
$698,442
$880,264
+26%
Net assets
2023
2024
Change
Restricted Net Assets
$1,630
$990
-39%
Unrestricted Net Assets
$3,164,147
$3,016,619
-5%
Net assets
2023
2024
Change
Net assets
+$3,165,777
+$3,017,609
-5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)